Premium
Characterization of [Nphe 1 ]nociceptin(1‐13)NH 2 , a new selective nociceptin receptor antagonist
Author(s) -
Calo' Girolamo,
Guerrini Remo,
Bigoni Raffaella,
Rizzi Anna,
Marzola Giuliano,
Okawa Hirobumi,
Bianchi Clementina,
Lambert David G,
Salvadori Severo,
Regoli Domenico
Publication year - 2000
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0703169
Subject(s) - nociceptin receptor , antagonist , agonist , receptor , chemistry , opioid receptor , endocrinology , medicine , receptor antagonist , chinese hamster ovary cell , pharmacology , opioid peptide , biology , opioid , biochemistry
Nociceptin (orphanin FQ) is a novel neuropeptide capable of inducing a variety of biological actions via activation of a specific G‐protein coupled receptor. However, the lack of a selective nociceptin receptor antagonist has hampered our understanding of nociceptin actions and the role of this peptide in pathophysiological states. As part of a broader programme of research, geared to the identification and characterization of nociceptin receptor ligands, we report that the novel peptide [Nphe 1 ]nociceptin(1‐13)NH 2 acts as the first truly selective and competitive nociceptin receptor antagonist and is devoid of any residual agonist activity. [Nphe 1 ]nociceptin(1‐13)NH 2 binds selectively to recombinant nociceptin receptors expressed in Chinese hamster ovary (CHO) cells (p K i 8.4) and competitively antagonizes the inhibitory effects of nociceptin (i) on cyclic AMP accumulation in CHO cells (pA 2 6.0) and (ii) on electrically evoked contractions in isolated tissues of the mouse, rat and guinea‐pig with pA 2 values ranging from 6.0 to 6.4. [Nphe 1 ]nociceptin(1‐13)NH 2 is also active in vivo , where it prevents the pronociceptive and antimorphine actions of intracerebroventricularly applied nociceptin, measured in the mouse tail withdrawal assay. Moreover, [Nphe 1 ]nociceptin(1‐13)NH 2 produces per se a dose dependent, naloxone resistant antinociceptive action and, at relatively low doses, potentiates morphine‐induced analgesia. Collectively our data indicate that [Nphe 1 ]nociceptin(1‐13)NH 2 , acting as a nociceptin receptor antagonist, may be the prototype of a new class of analgesics.British Journal of Pharmacology (2000) 129 , 1183–1193; doi: 10.1038/sj.bjp.0703169